Venker Eric Insider Trades

Insider Trading History

Track insider trading activity for Venker Eric. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $59.7M 1,632,972 shares
Last Trade
Aug 28, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.15M 200,000 shares
$35.77
$36.57
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $141M 3,844,834 shares
Last Trade
Aug 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.94M 200,000 shares
$34.71
$36.57
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $65.8M 1,799,154 shares
Last Trade
Aug 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.94M 200,000 shares
$34.71
$36.57
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $58.5M 1,599,154 shares
Last Trade
Aug 20, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$512k 13,909 shares
$36.84
$36.57
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $59M 1,613,063 shares
Last Trade
Jul 27, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.99M 200,000 shares
$34.95
$36.57
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $148M 4,044,834 shares
Last Trade
Jul 27, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.94M 200,000 shares
$34.72
$36.57
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $66.3M 1,813,063 shares
Last Trade
Jul 27, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.94M 200,000 shares
$34.72
$36.57
Immunovant
Immunovant IMVT
Chief Executive Officer
Holding Value $8.59M 254,280 shares
Last Trade
Jul 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$119k 3,092 shares
$38.48
$33.78
Immunovant
Immunovant IMVT
Chief Executive Officer
Holding Value $34.3M 1,014,062 shares
Last Trade
Jul 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.52M 92,188 shares
$38.14
$33.78
Immunovant
Immunovant IMVT
Chief Executive Officer
Holding Value $11.6M 344,001 shares
Last Trade
Jul 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.52M 92,188 shares
$38.14
$33.78
Immunovant
Immunovant IMVT
Chief Executive Officer
Holding Value $8.69M 257,372 shares
Last Trade
Jul 01, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.3M 86,629 shares
$38.14
$33.78
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $60.7M 1,659,297 shares
Last Trade
Jun 24, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.63M 200,000 shares
$33.16
$36.57
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $155M 4,244,834 shares
Last Trade
Jun 24, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.8M 200,000 shares
$34.01
$36.57
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $66.3M 1,813,063 shares
Last Trade
Jun 24, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.8M 200,000 shares
$34.01
$36.57
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $59M 1,613,063 shares
Last Trade
May 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.05M 200,000 shares
$30.27
$36.57
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $163M 4,444,834 shares
Last Trade
May 22, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.99M 200,000 shares
$29.96
$36.57
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $66.3M 1,813,063 shares
Last Trade
May 22, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.99M 200,000 shares
$29.96
$36.57
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $59M 1,613,063 shares
Last Trade
May 20, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.12M 34,483 shares
$32.41
$36.57
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $170M 4,644,834 shares
Last Trade
Apr 20, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.82M 200,000 shares
$29.08
$36.57
Roivant Sciences
Roivant Sciences ROIV
President & Immunovant CEO
Holding Value $67.6M 1,847,546 shares
Last Trade
Apr 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.82M 200,000 shares
$29.08
$36.57

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up